Why the study?
How is high-sensitivity cardiac troponin used in the differential diagnosis of suspected acute coronary syndrome?
How is high-sensitivity cardiac troponin used in the differential diagnosis of suspected acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
High-sensitivity cardiac troponin is a well-established quantitative marker of cardiomyocyte injury essential for the differential diagnosis of suspected acute coronary syndrome.
The role of cardiac troponins as diagnostic biomarkers of myocardial injury in the context of acute coronary syndrome (ACS) is well established. Since the initial 1st-generation assays, 5th-generation high-sensitivity cardiac troponin (hs-cTn) assays have been developed, and are now widely used. However, its clinical adoption preceded guidelines and even best practice evidence. This review summarizes the history of cardiac biomarkers with particular emphasis on hs-cTn. We aim to provide insights into using hs-cTn as a quantitative marker of cardiomyocyte injury to help in the differential diagnosis of coronary versus non-coronary cardiac diseases. We also review the recent evidence and guidelines of using hs-cTn in suspected ACS.
No takes yet. Share an insight, caveat, or question.
Garg et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: